MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer
Summary: Advanced prostate cancers are treated with therapies targeting the androgen receptor (AR) signaling pathway. While many tumors initially respond to AR inhibition, nearly all develop resistance. It is critical to understand how prostate tumor cells respond to AR inhibition in order to exploi...
Auteurs principaux: | Preston D. Crowell, Jenna M. Giafaglione, Anthony E. Jones, Nicholas M. Nunley, Takao Hashimoto, Amelie M.L. Delcourt, Anton Petcherski, Raag Agrawal, Matthew J. Bernard, Johnny A. Diaz, Kylie Y. Heering, Rong Rong Huang, Jin-Yih Low, Nedas Matulionis, Nora M. Navone, Huihui Ye, Amina Zoubeidi, Heather R. Christofk, Matthew B. Rettig, Robert E. Reiter, Michael C. Haffner, Paul C. Boutros, Orian S. Shirihai, Ajit S. Divakaruni, Andrew S. Goldstein |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Elsevier
2023-10-01
|
Collection: | Cell Reports |
Sujets: | |
Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2211124723012330 |
Documents similaires
-
ZFP36-mediated mRNA decay regulates metabolism
par: Andrew C. Cicchetto, et autres
Publié: (2023-05-01) -
Uptake of tumor-derived microparticles induces metabolic reprogramming of macrophages in the early metastatic lung
par: Kelly Kersten, et autres
Publié: (2023-06-01) -
Endothelial Jagged1 levels and distribution are post-transcriptionally controlled by ZFP36 decay proteins
par: Hannah L. Sunshine, et autres
Publié: (2024-01-01) -
AAV5-mediated manipulation of insulin expression in choroid plexus has long-term metabolic and behavioral consequences
par: Caio Henrique Mazucanti, et autres
Publié: (2023-08-01) -
Comparative transcriptomic profiling reveals a role for Olig1 in promoting axon regeneration
par: Xiu-Qing Fu, et autres
Publié: (2024-07-01)